MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202521015379 A) filed by Rungta International Skills University; Rungta College Of Engineering & Technology; and Rungta College Of Pharmaceutical Sciences And Research on February 22, 2025, for Process Of Formulating Euphorbia Neriifolia Extract Gel In Treating Diabetic Wound Infections.
Inventors include Sanjay Kumar Gupta; Devorat Singh; Sumit Sahu; Yamini Sahu; Priya Komre; Abhishek Kumar Om; Shrejal Sharma; Bhaskar Singh; and Harsh Meshram.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: Process of formulating Euphorbia Neriifolia Extract Gel in Treating Diabetic Wound Infections This invention describes a formulation of Euphorbia Neriifolia (EN) extract gel designed for the treatment of Escherichia coli-infected wounds in diabetic patients. The gel utilizes a Soxhlet extraction method with n-hexane to harness the antimicrobial and anti-inflammatory properties of EN, which are integrated into a Carbopol 934 gel base for sustained delivery. Methylparaben is included as a preservative, and triethanolamine is used to adjust the pH to skin-compatible levels. The gel effectively promotes wound contraction, re-epithelialization, reduces bacterial load, and enhances tissue regeneration, as demonstrated in diabetic patients. This therapeutic formulation addresses the critical need for effective wound management in diabetic patients, offering a potent alternative to standard treatments and enhancing the healing process through its bioactive phytochemical composition and optimized delivery system.
Disclaimer: Curated by HT Syndication.
